会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 23. 发明申请
    • COHESIVE NON-FREE FLOWING SWEETENER COMPOSITIONS CONTAINING DISINTEGRANT
    • 含有消毒剂的非自由流动感应器组合物
    • US20080069934A1
    • 2008-03-20
    • US11532687
    • 2006-09-18
    • Renny IsonMelanie LoadesGareth Williams
    • Renny IsonMelanie LoadesGareth Williams
    • A23L1/236
    • A23L27/33A23L27/30A23L27/31A23L27/32
    • Cohesive non-free flowing compositions for adding sweetness to liquid foodstuffs, for example, beverages, having a reduced caloric burden as compared to conventional sucrose cubes, are provided. More particularly, a low calorie Cohesive non-free flowing compositions containing a high intensity sweetener, a bulking agent, and a disintegrant, wherein a sweetener cube formed from the cohesive non-free flowing sweetener composition having about the same dimensions as a convention sucrose cube has a lower caloric burden and an equivalent sweetness is disclosed. Also provided are cohesive non-free flowing compositions containing sucralose, carboxymethyl cellulose, polydextrose, trehalose, and erythritol, wherein a sweetener cube formed from the cohesive non-free flowing composition having about the same dimension as a conventional sucrose cube has a lower caloric burden and a equivalent sweetness. Methods of making such sweetener cubes are also provided.
    • 提供了与常规蔗糖立方体相比具有降低热量负担的液体食品例如饮料的甜味的粘性非自由流动性组合物。 更具体地,含有高强度甜味剂,填充剂和崩解剂的低热量粘性非自由流动组合物,其中由内聚非自由流动甜味剂组合物形成的甜味剂立方体具有与常规蔗糖立方体大致相同的尺寸 具有较低的热量负担,并且公开了相当的甜度。 还提供了含有三氯蔗糖,羧甲基纤维素,聚右旋糖,海藻糖和赤藓糖醇的内聚非自由流动组合物,其中由具有与常规蔗糖立方体相同尺寸的内聚非自由流动组合物形成的甜味剂立方体具有较低的热量负担 和相当的甜度。 还提供了制备这种甜味剂立方体的方法。
    • 27. 发明授权
    • Method and associated kit utilizing international organization for standardization container filter house
    • 方法和相关套件利用国际组织标准化集装箱过滤房
    • US08500838B2
    • 2013-08-06
    • US12780160
    • 2010-05-14
    • Anthony Richard PikeAlun Gareth Williams
    • Anthony Richard PikeAlun Gareth Williams
    • B01D46/00
    • B01D46/42B01D46/0013B01D46/002B01D46/0045B01D46/10B01D46/429B01D46/446B01D46/448B01D2279/60
    • A method of using a modular International Organization for Standardization (ISO) filter house for filtering process fluids is provided. The filter house includes a self-contained rectangular cuboid enclosure having the outside dimension of a standard, transportable ISO shipping container. The filter house has apertures for fluid flow inlet and fluid flow outlet, and a filter element for removing impurities from the fluid flow. The method includes creating one standard filter house design to be used in any multiple to meet various flow requirements. The method further includes creating a common fluid connection between the filter houses and process equipment so that the filter houses operate in parallel. A kit of modular components for filtration of a fluid is also provided. The kit includes an external structure of an ISO shipping container, vanes to direct fluid flow, and a filter element. The kit also includes apertures that allow fluid communication between the interior of the shipping container and the exterior of the shipping container.
    • 提供了一种使用模块化国际标准化组织(ISO)过滤器过滤器过滤器的方法。 过滤房包括一个独立的矩形长方体外壳,具有标准的可运输的ISO运输容器的外部尺寸。 过滤器室具有用于流体流入口和流体流出口的孔,以及用于从流体流中去除杂质的过滤元件。 该方法包括创建一个标准过滤器房屋设计,以便在任意多个位置使用以满足各种流量要求。 该方法还包括在过滤器室和处理设备之间创建公共流体连接,使得过滤器室并行操作。 还提供了一套用于过滤流体的模块化部件。 该套件包括ISO运输容器的外部结构,用于引导流体流动的叶片和过滤元件。 套件还包括允许运输容器的内部和运输容器的外部之间流体连通的孔。
    • 30. 发明授权
    • Inhibitors of IKK-beta serine-threonine protein kinase
    • IKK-β丝氨酸 - 苏氨酸蛋白激酶抑制剂
    • US08106091B2
    • 2012-01-31
    • US12447271
    • 2007-10-29
    • David Charles Festus MoffatStephen John DaviesMichael Hugh CharltonSimon Christopher HirstStuart Thomas OnionsJonathon Gareth Williams
    • David Charles Festus MoffatStephen John DaviesMichael Hugh CharltonSimon Christopher HirstStuart Thomas OnionsJonathon Gareth Williams
    • A61K31/381C07D333/36
    • C07D333/38
    • Compounds of formula (IA) or (IB) are inhibitors of IkB kinase (IKK) activity, and are useful in the treatment of autoimmune and inflammatory diseases: wherein R7 is hydrogen or optionally substituted (C1-C6)alkyl; ring A is an optionally substituted aryl or heteroaryl ring of 5-13 ring atoms; Z is a radical of formula R-L1-Y1—(CH2)z—, wherein: z is 0 or 1; R is a radical of formula (X) or (Y) R1 is a carboxylic acid group (—COOH), or an ester group which is hydrolysable by one or more intracellular esterase enzymes to a carboxylic acid group; R6 is hydrogen, or optionally substituted C1-C6 alkyl, C3-C7 cycloalkyl, aryl or heteroaryl or —(C═O)R3, —(C═O)OR3, or —(C═O)NR3 wherein R3 is hydrogen or optionally substituted (C1-C6)alkyl; Y1 is a bond, —(C═O)—, —S(O2)—, —C(═O)O—, —OC(═O)—, —(C═O)NR3—, —NR3(C═O)—, —S(O2)NR3—, —NR3S(O2)—, or —NR3(C═O)NR4—, wherein R3 and R4 are independently hydrogen or optionally substituted (C1-C6)alkyl, L1 is a divalent linker radical of formula -(Alk1)m(Q)n(Alk2)p- wherein m, n, p, Q, Alk1 and Alk2 are as defined in the claims.
    • 式(IA)或(IB)的化合物是IkB激酶(IKK)活性的抑制剂,可用于治疗自身免疫性和炎性疾病:其中R 7为氢或任选取代的(C 1 -C 6)烷基; 环A是任选取代的5-13个环原子的芳基或杂芳基环; Z是式R-L1-Y1-(CH2)z-的基团,其中:z是0或1; R是式(X)或(Y)的基团,R 1是羧酸基团(-COOH)或可被一个或多个细胞内酯酶水解成羧酸基团的酯基; R 6是氢或任选取代的C 1 -C 6烷基,C 3 -C 7环烷基,芳基或杂芳基或 - (C = O)R 3, - (C = O)OR 3或 - (C = O)NR 3,其中R 3是氢或 任选取代的(C 1 -C 6)烷基; Y1是一个键, - (C = O) - , - S(O 2) - , - C(= O)O-,-OC(= O) - , - (C = O)NR 3 - , - NR 3 (O) - , - S(O 2)NR 3 - , - NR 3 S(O 2) - 或-NR 3(C = O)NR 4 - ,其中R 3和R 4独立地是氢或任选取代的(C 1 -C 6) 式 - (Alk1)m(Q)n(Alk2)p的二价连接基团其中m,n,p,Q,Alk1和Alk2如权利要求中所定义。